Document is current
Any future updates will be listed below
-
Authors
Abla, Nada
Marrast, Anne Claire
Jambert, Elodie
Richardson, Naomi
Duparc, Stephan
Almond, Lisa
Rowland Yeo, Karen
Pan, Xian
Tarning, Joel
Zhao, Ping
Culpepper, Janice
Waitt, Catriona
Koldeweij, Charlotte
Cole, Susan
Butler, Andrew S.
Khier, Sonia
Möhrle, Jörg J.
El Gaaloul, Myriam
-
Funding
Funding for this research was provided by:
Wellcome Trust (220211)
- License Information
-
More Information
Article History
Received: 2 May 2024
Accepted: 13 September 2024
First Online: 27 September 2024
Declarations
:
: Not applicable.
: Not applicable.
: NA, ACM, EJ, SD, JJM and MEG are employees of MMV Medicines for Malaria Venture. PZ and JC are employees of the Bill & Melinda Gates Foundation. LA, KRY and XP are employees of Certara Ltd and may hold shared in the company. NR is a paid consultant for MMV Medicines for Malaria Venture. SK is employee of Montpellier University. CW is funded by Wellcome Clinical Research Career Development Fellowship (222075_Z_20_Z). CK is funded by the Bill & Melinda Gates Foundation (INV-023795). AB and SC work for the Medicines and Healthcare products Regulatory Agency and are funded by the Bill & Melinda Gates Foundation (INV-009383). JT declares no competing interests.
